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Abstract
Background:  The   conventional   right   ventricular   (RV)   lead   position   in   cardiac 
resynchronization therapy pacemakers (CRT-P) is the RV apex (RV-A). Little is known 
about electrophysiological stability and associated complications of pacing leads in RV high 
posterior septal (RV-HS) position in CRT-P.                                                      
Methods: Two hundred and thirty-five consecutive CRT-P patients were included from 1999-
2010. Pacing thresholds at 0.5ms and 2.5V, sensing electrograms and lead impedances were 
measured   at   implant   and   repeated   1,3,6,12,18   and   24   months   after   CRT-P. 
Electrophysiological measurements of leads located in RV-A and RV-HS were analyzed 
retrospectively. Bipolar RV leads were used, including high impedance leads, passive 
fixation and active fixation.                                                                                                     
Results: RV pacing leads were implanted in RV-A (n=79) and RV-HS (n=156). Average RV 
pacing thresholds from CRT implant procedure to 24-month follow-up at 0.5ms were 
0.77±0.69V in RV-A and 0.71±0.35V in RV-HS (P=0.31), and at 2.5V were 0.06±0.08ms in 
RV-A and 0.07±0.05ms in RV-HS (P=0.12). Average RV electrogram amplitudes from 
baseline to 24 months after CRT were 15.3±6.9mV in RV-A and 12.1±6.0mV in RV-HS 
(P=0.55).   Average   RV   impedances   during   follow-up   were   850±286Ω   in   RV-A   and 
618±147Ω in RV-HS (P=0.57). Similar RV lead revisions between RV-A and RV-HS were 
observed after 2-year follow-up (P=0.55).                                              
Conclusions: The RV-HS lead position demonstrated stable and acceptable long-term pacing 
and sensing function, with rates of complications comparable to conventional RV-A lead 
position in CRT. The RV-HS lead position is feasible in CRT-P.                                               
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Introduction
            
Cardiac resynchronization therapy (CRT) is the recommended treatment in symptomatic 
heart failure (HF) patients on optimal medical treatment with left ventricular (LV) systolic 
dysfunction and prolonged QRS duration.[1-3] The conventional right ventricular (RV) lead 
placement in CRT has been at the RV apex (RV-A).[4] Recent studies on the detrimental 
effects of RV-A pacing on LV function in treating bradyarrhythmias has increased the 
interest   in   alternate   RV   pacing   sites.[5-6]   The   electrophysiological   performance   and 
associated complications of selective site pacing in the interventricular septum of the RV 
outflow tract (RVOT) and RV mid septum has been studied in patients with a bradycardia 
indication for permanent pacing.[7-8]  In CRT, several studies have demonstrated the long-
term   electrophysiological   stability   and   associated   complications   of   conventional   lead 
placement.[9-12] Alternate RV lead position in CRT has demonstrated similar hemodynamic 
effects as RV-A in previous studies.[13-16] However, there are few data concerning long-
term electrophysiological stability and associated complications in alternate RV pacing sites 
in   CRT.                                                                                  
We hypothesized that a RV high posterior septal (RV-HS) lead position in CRT would 
provide similar long-term pacing and sensing stability as compared to the conventional RV-
A. Thus, the aim of this study was to compare the electrophysiological performance of RV-
HS lead position in CRT pacemakers (CRT-P) to previously implanted RV-A in a two-year 
follow-up. The challenges encountered with the RV-A and RV-HS lead implant procedure 
and   need   for   lead   revisions   during   the   first   two   years   were   investigated.  
Methods
Patient Population                                                                                             
In this study, 237 consecutive HF patients referred to CRT pacemaker (CRT-P) implantation 
were included between 1999 and 2010. Inclusion criteria were HF patients on optimal 
medical treatment in New York Heart Association (NYHA) functional class III-IV, LV 
ejection fraction (LVEF) ≤ 35%, LV end-diastolic diameter ≥ 5.5 cm and QRS duration ≥ 
120ms. The regional ethics committee approved this study, and the patients were included 
after informed consent.                                                                                     
Study Protocol                                                                                                           
RV pacing thresholds at 0.5ms and 2.5V, respectively, sensing R-wave amplitudes and lead 
impedances   at   5.0V   pacing   were   measured   during   the   pacemaker   implantation.   All 
measurements were repeated at follow-up 1, 3, 6, 12, 18 and 24 months after CRT. 
Pacemaker testing was performed by using Medtronic CareLink® pacemaker programmer 
(Medtronic, Minneapolis, MN, USA). Patients in need of lead revisions re-started the same 
routine  follow-up intervals.                                                                              
 
CRT Implantation  Procedure                                                                           
A CRT pacing system was implanted under local anaesthesia with a transvenous introduction 
of the leads via the left cephalic or subclavian vein using different bipolar RV leads (Table 
1). Two experienced implanters (SF,TH) performed the CRT-P implant procedures. Both 
CRT implanters placed the RV leads in RV-A and RV-HS equally distributed. During the 
first six years of CRT implantation the conventional RV-A lead placement was used at our 
center. The RV-HS lead placement was selected in the majority of the patients from 2005 
although the choice of lead position was left to the discretion of the implanting physician. 
The RV lead positions were achieved guided by fluoroscopy using three standard views as a 
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routine: anteriorposterior view (AP), left anterior oblique 30º view (LAO) and right anterior 
oblique 30º view (RAO). The RV-A lead position was defined as the distal part of RV lead 
close to or below the silhouette of left diaphragm visualized in the AP fluoroscopic view.[17] 
In LAO view RV-A position was demonstrated by a straight or slightly curved anterior lead 
direction (Figure 1). In RAO fluoroscopic view the RV-A position was confirmed by an 
anterior direction of the leads with the tip electrode close to the inferior part of the sternum. 
This view was also used primarily to avoid lead positioning in RV free wall or in the middle 
or lateral cardiac vein. The RV-A lead position was achieved by using conventional bipolar 
RV pacing leads (n=79) with a stylet. RV-HS lead placement was defined positioning in the 
inferior part of the RVOT in AP fluoroscopy view with a posterior lead tip orientation in 
fluoroscopic LAO view [17] (Figure 2). The RAO fluoroscopic view was used to ensure that 
the RV lead was not positioned in the coronary sinus (CS) or great cardiac vein. For the first 
consecutive 107 patients, the RV-HS lead position was obtained by using the Select Secure 
systemTM (Medtronic, Minneapolis, MN, USA) with deflectable guide catheter. For the next 
49 patients, conventional bipolar RV pacing leads with preshaped stylets were used. 
Table 1. Right Ventricular Bipolar Pacing leads.*
* Medtronic, Minneapolis, MN, USA; RV-A = right ventricular (RV) apical lead position; RV-HS = RV high 
posterior septal lead position.
The first method to achieve the RV-HS lead position was a catheter based lead delivery 
system.[18] The deflectable guide catheter was tracked over a guidewire into the RV before 
the guidewire was removed and replaced by the lumenless RV lead. The lead was advanced 
to near the catheter tip and the guide catheter was then deflected and positioned to the inferior 
part of RVOT and to the posterior part of interventricular septum by counterclockwise 
rotation of the catheter. After reaching the desired implant site, the lead was advanced to the 
myocardium and fixated by the tip screw, and the deflectable catheter carefully removed. The 
RVOT position was verified by AP view, and posterior pointing verified in LAO view.
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Figure 1. RV-A lead (1; Medtronic 4076) placement in fluoroscopic anteroposterior (AP) and left anterior 
oblique 30º view (LAO). The coronary venous lead (2; Medtronic 4193) is also shown. RV-A = right ventricular 
apical   lead   placement.                                                                          
Figure 2. RV-HS lead (1; Medtronic 4076) placement in flouroscopic anteroposterior (AP) and left anterior 
oblique 30º view (LAO). The coronary venous lead (2; Medtronic 4193) is also shown. RV-HS = right 
ventricular   high   posterior   septal   lead   placement.                                                                
The second method of obtaining the RV-HS lead position was by using a conventional pacing 
lead manoeuvred by preshaped stylets.[19] First, the lead was advanced to the pulmonary 
artery facilitated by a curved stylet. Next, a second preshaped stylet resembling a swan neck 
was introduced to the lead tip. This stylet had a generous primary curve and a terminal 2cm 
bend to form a secondary curve. The secondary swan neck curve was further modified to 
make the terminal 2cm of the stylet point in a posterior direction. The RV lead was carefully 
pulled back from the pulmonary artery during slight counterclockwise rotation of the stylet to 
facilitate a posterior direction of the lead tip to move to the posterior interventricular septum 
of the RVOT. The position of the lead tip pointing posteriorly was verified in the LAO view 
before the lead was fixed by the tip screw to the myocardial wall.                              
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The CS leads were placed in a lateral or posterolateral CS vein tributary from AP and LAO 
view.20 The right atrial leads were positioned in right appendage demonstrated by an anterior 
and upward position of the distal part of the in the RAO view.[17]                           
Statistical   Analysis                                                                                  
Statistical analyses were performed using SPSS software version 18.0 (SPSS, Chicago, IL).  
All variables are expressed as mean ± SD. Continuous variables were compared by using 
Student t-test.   Time-related repeated measurements and were compared by ANOVA for 
repeated  measurements  with  Greenhouse–Geisser  correction.  Nonparametric  data  were 
analyzed by Pearson χ2 or Fisher's exact test. P-value of < 0.05 was considered statistically 
significant.
Results
Patient   population                                                                            
Out of 237 patients referred for CRT-P, 158 were selected for RV lead placement in RV-HS 
position. In 2 patients we failed to achieve this lead position (1.3% failure rate), and both 
were   successfully   repositioned   to   RV-A,   and   were   excluded   from   further   analysis. 
Accordingly, the study group consisted of 235 CRT-P patients: 79 patients with RV-A lead 
position and 156 with RV-HS lead position. Baseline characteristics of the study patients are 
listed in Table 2. 
Table 2.  Baseline Characteristics of the Patients According to Right Ventricular Position.
RV-A = right ventricular (RV) apical lead position; RV-HS = RV high posterior septal lead position; NYHA = 
New York Heart Association; LVEF = LV ejection fraction; LVEDD = LV end-diastolic diameter; ACEI = 
angiotensin-converting enzyme inhibitors; ARB = angiotensin receptor blockers.
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Pacing   Thresholds                                                                              
The average voltage pacing thresholds and pulse duration pacing threshold at 0.5ms and 2.5V 
respectively, in RV-A and RV-HS, are demonstrated in Figure 3 and 4. From implant to 24 
months after CRT, the RV average voltage pacing threshold at 0.5ms remained stable at 
0.77±0.69V in RV-A (P=0.09) and 0.71±0.35V in RV-HS (P=0.31). From baseline to 24-
month follow-up, the average RV pulse duration pacing threshold at 2.5V was stable at 
0.06±0.08ms in RV-A (P=0.43) and 0.07±0.05ms in RV-HS (P=0.12). The average pacing 
threshold from CRT implantation to 24 months after CRT were similar between RV-A and 
RV-HS, measured at 0.5ms (p=0.43) and at 2.5V (p=0.12).
Figure 3.  Pacing thresholds at 0.5ms pulse duration measured at baseline and at different follow-up periods 
between RV-A (blue) and RV-HS (green). Abbreviations as in Figure 1 and 2. 
Figure 4.  Pacing thresholds at 2.5V measured at baseline and at different follow-up periods between RV-A 
(blue) and RV-HS (green). Abbreviations as in Figure 1 and 2.                                                                     
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Sensing Electrogram Amplitudes and Lead Impedances                                               
The average sensing electrogram amplitudes and lead impedances from RV-A and RV-HS 
are illustrated in Figure 5 and 6. From implant to 24 months after CRT, the average sensing 
amplitudes were stable at 15.3±6.9mV in RV-A (P=0.55) and 12.1±6.0mV in RV-HS 
(P=0.78), and were comparable between the two RV lead positions (P=0.55). From baseline 
to 24-month follow-up, the lead impedances decreased and averaged at 850±286Ω in RV-A 
(P=0.003) and 618±147Ω in RV-HS (P<0.001), but were not different between the RV-A and 
RV-HS lead position (P=0.57).
Figure 5.  Sensing amplitude threshold measured at baseline and at different follow-up periods between RV-A 
(blue) and RV-HS (green). Abbreviations as in Figure 1 and 2.                                                     
Figure 6.  Lead impedances measured at baseline and at different follow-up periods between RV-A (blue) and 
RV-HS (green). Abbreviations as in Figure 1 and 2.                                                                                 
Operative   observations                                                                              
Operative observations are listed in Table 3. The main operative challenges for both RV lead 
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positions  were either high pacing threshold or low R-wave amplitudes  that required 
repositioning of the RV lead. Repositioning procedures of the RV lead was targeted towards 
finding a location as close as possible to the original implant site with acceptable pacing and 
sensing function. In 8 patients (RV-HS; n=6) it was difficult to achieve the anatomically 
appropriate RV lead positions and several lead position attempts were needed to obtain the 
targeted site. There were 4 intraoperative lead dislodgements (RV-HS; n=3) that were 
successfully corrected during the primary operation. No major complications related to RV 
lead  placements  were  observed.                                                                       
Table 3. Operative Observations.
RV-A = right ventricular (RV) apical lead position; RV-HS = RV high posterior septal lead position.
Late Lead Revisions                                                                                                             
Out of the 120 patients with RV-HS lead placement that reached two-year follow-up (lead 
model 3038; n=107; lead model 4076; n=13), RV lead revisions were necessary for 3 patients. 
They all had the lead model 3830. For one patient, lead revision was done after 3 days due to 
loss of pacing capture without lead dislodgement. For the other two patients, revisions were 
completed after 106 days and 491 days, respectively, due to lead dislodgements. Of the 60 
patients with RV-A lead positions that reached two-year follow-up, no RV leads had to be 
revised. The lead revisions performed in the two RV lead positions two years after CRT were 
similar   (P=0.55).                                                                        
Discussion
The main finding of this 2-year follow-up comparing the electrophysiological performance of 
alternate RV lead position in CRT-P can be summarized as follows: 1) similar and stable 
pacing and sensing function in both RV-A and RV-HS during long-term CRT-P; 2) decreasing 
RV lead impedances during follow-up, but comparable findings between the two RV lead 
positions; 3) similar operative challenges and late RV lead revisions in RV-A and RV-HS. 
To  our  knowledge,   the  current  study  is  the   first   to   compare  the   electrophysiological 
performance of alternate RV lead position in CRT-P. Previous studies have demonstrated the 
pacing lead stability and sensing function in RV-A as compared to alternate RV lead position 
in bradycardia indication for permanent pacing. Burri et al [8] studied 362 pacemaker 
recipients, and found similar pacing- and sensing lead performance and need for RV lead 
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repositioning between RV-A and RVOT. The long-term stability of RV-mid septal position 
was reported by Medi et al [7], in 100 pacemaker patients. The current study demonstrated 
similar long-term electrophysiological performance between RV-A and RV-HS in CRT-P, in 
accordance with previous findings of alternate RV lead position in permanent pacing for 
bradycardia. However, the CRT patients with moderate-to-severe heart failure and remodelled 
hearts might be structurally different from the typical population of bradypacing. Moreover, the 
present study demonstrates that RV-HS lead position is feasible also in CRT-P patients, 
including two different methods for placement of the RV-HS lead.                                     
RV lead impedances can decrease on long-term follow-up, but might also be dependant on RV 
lead characteristics. [7,8] A decrease in RV-lead impedance was observed in the current study, 
similar as the aforementioned studies. Different RV leads were used in the present study, 
including 47 of the 79 high-impedance RV-A leads [21], and this might have influenced on the 
electrophysiological results. The reported complications to alternate RV lead placement in 
bradycardia-pacing have been similar as in RV-A. [8] The present study found comparable 
intraoperative   challenges   and   reinterventions   between   the   two   RV   lead   positions.   We 
experienced 3 lead revisions in RV-HS and none in RV-A during two-year follow up, but not 
statistical   significant   different.                                                                      
Clinical   implications                                                                            
The current study demonstrates that the RV-HS lead position is feasible in CRT-P. The RV-A 
position in CRT is preferred in CRT, and has demonstrated long-term stability. [4] Moreover, it 
is essential that any alternate positions to the conventional RV-A in CRT maintain similar 
long-term stability. Furthermore, the influence of RV lead position on LV reverse remodelling 
is uncertain, but alternate RV lead position in CRT is feasible as reported in the present study. 
Large prospective randomized trials are needed to identify the optimal RV lead position in 
CRT.
Study   limitations                                                                        
The   present   retrospective   single-centre   study   may   be   limited   as   the   there   were   no 
randomization of the RV lead positions. Furthermore, the patients were slightly different at 
baseline as the patients with RV-A lead position suffered from more severe HF. The study 
population might bee too small or the duration of the follow-up period too short to identify 
differences in electrophysiological lead stability or complication rates between the two RV lead 
positions. Different RV leads, including active and passive fixation leads, were used, with 
differences in pacing surface area and anode-cathode distance, which can influence the results 
in   this   study.                                                                                              
Conclusion
The present study demonstrate that RV-HS lead position is feasible in CRT-P, with similar 
long-term pacing and sensing functions and associated complications as the conventional RV-
A lead placement.                                                                                              
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